EGFR and breast carcinoma: Indeed, ErbB2 amplification is a hallmark of human breast cancer, and a number of ErbB ligands are highly expressed in breast tumors, including the EGFR ligand TGFα and the ErbB3/ErbB4 ligand HRG [21, 22, 24, 48, 49].